Ruilope L M, Lahera V, Rodicio J L
Unidad de Hipertensión, Hospital 12 de Octubre, Madrid, Spain.
J Cardiovasc Pharmacol. 1994;23 Suppl 5:S49-53. doi: 10.1097/00005344-199423005-00010.
Calcium antagonists exert renal effects consisting mainly of renal vasodilation and facilitation of renal excretion of sodium through a direct action on renal tubules. These effects facilitate the antihypertensive action of this class of drugs and make them suitable for therapy of different forms of human hypertension, including that accompanying chronic renal failure. At the same time, renal vasodilation and enhanced natriuresis could also be of value for correcting the renal defect that initiates essential hypertension. Renal effects of calcium antagonists have also fostered the concept of a renoprotective effect of these drugs in different situations. A demonstration of this concept has been shown in cyclosporine-related nephrotoxicity. Calcium antagonists can improve the short- and long-term prognosis for renal function in human transplantation through their effects in avoiding cyclosporine-induced renal vasoconstriction and in facilitating renal sodium output.
钙拮抗剂对肾脏的作用主要包括肾血管舒张以及通过对肾小管的直接作用促进钠的肾排泄。这些作用有助于此类药物的降压作用,使其适用于治疗不同类型的人类高血压,包括伴有慢性肾衰竭的高血压。同时,肾血管舒张和增强的利钠作用对于纠正引发原发性高血压的肾脏缺陷也可能具有重要意义。钙拮抗剂的肾脏作用还促成了这些药物在不同情况下具有肾脏保护作用这一概念。在环孢素相关肾毒性方面已证实了这一概念。钙拮抗剂可通过避免环孢素引起的肾血管收缩以及促进肾钠排出的作用,改善人类移植肾功能的短期和长期预后。